tiprankstipranks
Cynata Therapeutics Applies for ASX Quotation
Company Announcements

Cynata Therapeutics Applies for ASX Quotation

Cynata Therapeutics Limited (AU:CYP) has released an update.

Don't Miss Our Christmas Offers:

Cynata Therapeutics Limited has announced an application for the quotation of 125,000 newly issued ordinary fully paid securities on the ASX under the code CYP, with the issue date set for September 2, 2024. This move, part of a transaction previously communicated to the market, marks a new announcement for the biotechnology company.

For further insights into AU:CYP stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskCynata Therapeutics Announces Key Shareholder Meeting and Trial Updates
TipRanks Australian Auto-Generated NewsdeskCynata Therapeutics Raises $8.1M After Positive Trial Results
TipRanks Australian Auto-Generated NewsdeskCynata’s CYP-006TK Shows Promise in Diabetic Foot Ulcer Trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App